MicroRNAs (miRNAs; miRs) are small non-coding ribonucleic acids sequences vital in
regulating gene expression. They are significant in many biological and pathological …

Noninvasive imaging of the heart plays an important role in the diagnosis and management
of pulmonary hypertension (PH), and several well-established techniques are available for …

Pulmonary hypertension (PH) is a fatal and untreatable disease, ultimately leading to right
heart failure and eventually death. microRNAs are small, non-coding endogenous RNA …

Background Pulmonary arterial hypertension (PAH) is often characterized by cell
proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs). LncRNA …

Pulmonary arterial hypertension (PAH) pathobiology involves a remodeling process in distal
pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to enhanced …

Therapeutic approaches in pediatric pulmonary arterial hypertension (PAH) are based
primarily on clinician experience, in contrast to the evidence-based approach in adults with …

Highlights•miRNA expression is generally tissue specific and regulated in time.•miRNAs
could be used as biomarkers and new potential therapies.•miRNAs function as upstream …

Pediatric pulmonary arterial hypertension (PAH) is an uncommon disease that can occur in
neonates, infants, and children, and is associated with high morbidity and mortality. Despite …

Pulmonary arterial hypertension (PAH) is characterized by persistent pulmonary
vasoconstriction and pulmonary vascular remodeling. The pathogenic mechanisms of PAH …

As hypertension, almost 90% of cases of hypertension with an unknown origin called as
essential hypertension, continues to be one of the most important risk factors for various fatal …